HKG:1177 Sino Biopharm operates in the field of Medicine. The Group’s business works in a fully integrated chain which spans from R&D to manufacture and sales of pharmaceutical products, covering a vast array of biopharmaceutical, chemical and modernized Chinese medicines. Interim result 2022 are favorable for dividends (+200%) yet EPS fell 77%
HKG:1177 Sino Biopharm
Last update: 8-Jun-23
Quick overview:
-
- Yield: 3.12%
(See here Top 10 highest yield)
-
- Lot: 1000
- Price/Earnings ratio : 29.62 (Ideal <20 )
- Earnings per share : 0.130 (Ideal >0.001)
- Price as per 8-Jun-23 : HK$3.85
- Ex-Dividend Date coming up: 20-Jun-23
See here all upcoming Ex-Dividend dates
Log in, to see this page |
FREE: 25 highest yield Dividend Growth Stocks Yes for FREE, no spam. |